Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD) Guide Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD) Prepare for ICH M15 guideline: Learn how to assess model credibility, align terminology, and strengthen…Certara2026 年 2 月 13 日
Certara IQ™ Global Roadshow Live Events Certara IQ™ Global Roadshow Certara IQ™ is going on the road. From APAC to Europe to North America, our…Certara2026 年 2 月 12 日
Pediatric Drug Development: From “Wild West” to Model-Informed Confidence Blog Pediatric Drug Development: From “Wild West” to Model-Informed Confidence Model-informed drug development and precision dosing are transforming pediatric programs, from regulatory planning to Bayesian…Certara2026 年 2 月 11 日
Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants Publication Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…Certara2026 年 2 月 2 日
How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most Blog How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most Learn how Model-Informed Drug Development strengthens drug asset valuation by reducing uncertainty, predicting clinical performance,…Certara2026 年 1 月 26 日
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients Publication Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients This article explores how model-based meta-analysis (MBMA) performs when combining aggregate data and individual patient…Certara2026 年 1 月 22 日
Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy On-Demand Webinar Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…Certara2026 年 1 月 22 日
CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access Webinar CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access Certara2026 年 1 月 14 日
Regulatory Horizons: Strategic Global Insights & 2026 Outlook from Former Leaders of Major Regulatory Agencies On-Demand Webinar 监管前沿:全球战略洞察与 2026 展望,来自主要监管机构前任领导者的洞见 Watch this on-demand webinar featuring former regulators as they share global regulatory trends and clinical…Certara2026 年 1 月 14 日